ACETAMINOPHEN AND CODEINE PHOSPHATE

Post-LOE

acetaminophen and codeine phosphate

PharmaIN

ANDAORALTABLET

Approved

Jun 2019

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

ACETAMINOPHEN AND CODEINE PHOSPHATE (acetaminophen and codeine phosphate) by PharmaIN is clinical pharmacology mechanism of action codeine is an opioid agonist relatively selective for the mu-opioid receptor, but with a much weaker affinity than morphine. Approved for mild to moderate pain, where treatment with an opioid is appropriate, for which alternative treatments are inadequate. First approved in 2019.

Drug data last refreshed 18h ago

Mechanism of Action

CLINICAL PHARMACOLOGY Mechanism of Action Codeine is an opioid agonist relatively selective for the mu-opioid receptor, but with a much weaker affinity than morphine. The analgesic properties of codeine have been speculated to come from its conversion to morphine, although the exact mechanism of…

Worked on ACETAMINOPHEN AND CODEINE PHOSPHATE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

ACETAMINOPHEN AND CODEINE PHOSPHATE

Mechanism of Action

Indications (3)